The Epidemiology and Clinical Presentation of Lassa Fever: Information for Medical Providers
<a href="/items/browse?advanced%5B0%5D%5Belement_id%5D=49&advanced%5B0%5D%5Btype%5D=is+exactly&advanced%5B0%5D%5Bterms%5D=Training+and+Exercises">Training and Exercises</a>
<h2>Learn to Identify Lassa Fever</h2>
<p>While viral hemorrhagic fevers (VHFs), like Lassa fever, are very serious, they are not common in the U.S. However, it is important for healthcare providers to understand high consequence viruses, like Lassa fever, so they can appropriately diagnose and care for their patients. This video, the first in a two-part training series on Lassa fever, provides an overview, describing the epidemiology and clinical presentation of the virus.</p>
<a href="/items/browse?advanced%5B0%5D%5Belement_id%5D=39&advanced%5B0%5D%5Btype%5D=is+exactly&advanced%5B0%5D%5Bterms%5D=CDC">CDC</a>
2019-01-31
2023-10-17 by Darrell Ruby, T&E group
2025-10-17
Diagnose and Treat Lassa Fever Video Training: Information for Medical Providers
<a href="/items/browse?advanced%5B0%5D%5Belement_id%5D=49&advanced%5B0%5D%5Btype%5D=is+exactly&advanced%5B0%5D%5Bterms%5D=Training+and+Exercises">Training and Exercises</a>
<h2>Learn to diagnose and treat Lassa fever</h2>
<p>While viral hemorrhagic fevers (VHFs), like Lassa fever, are very serious, they are not common in the U.S. However, it is important for healthcare providers to understand high consequence viruses, like Lassa fever, so they can appropriately diagnose and care for their patients. This video is the second in a two-part training series on Lassa fever for healthcare providers. It focuses on methods for diagnosing Lassa fever and infection control measures to consider while caring for a patient with Lassa fever. Participants will learn about treatment options, as well as post-exposure prophylaxis (PEP).</p>
<a href="/items/browse?advanced%5B0%5D%5Belement_id%5D=39&advanced%5B0%5D%5Btype%5D=is+exactly&advanced%5B0%5D%5Bterms%5D=CDC">CDC</a>
2019-01-31
2023-10-17 by Darrell Ruby, T&E group
2025-10-17
Surveillance Case Definitions for Current and Historical Conditions
<a href="/items/browse?advanced%5B0%5D%5Belement_id%5D=49&advanced%5B0%5D%5Btype%5D=is+exactly&advanced%5B0%5D%5Bterms%5D=Treatment+%26+Care">Treatment & Care</a>
<p>A surveillance case definition is a set of uniform criteria used to define a disease for public health surveillance. Surveillance case definitions enable public health officials to classify and count cases consistently across reporting jurisdictions. Surveillance case definitions are not intended to be used by healthcare providers for making a clinical diagnosis or determining how to meet an individual patient’s health needs.</p>
<p>While the list of reportable conditions varies by state, the Council of State and Territorial Epidemiologists (CSTE) has recommended that state health departments report cases of selected diseases to CDC’s National Notifiable Diseases Surveillance System (NNDSS). Every year, case definitions are updated using CSTE’s Position Statements. They provide uniform criteria of national notifiable infectious and non-infectious conditions for reporting purposes.</p>
<a href="/items/browse?advanced%5B0%5D%5Belement_id%5D=39&advanced%5B0%5D%5Btype%5D=is+exactly&advanced%5B0%5D%5Bterms%5D=CDC">CDC</a>
2021-04-16
Ecology of Emerging Zoonotic Diseases
<a href="/items/browse?advanced%5B0%5D%5Belement_id%5D=49&advanced%5B0%5D%5Btype%5D=is+exactly&advanced%5B0%5D%5Bterms%5D=General">General</a>
This webinar discusses Nipah virus and Ebola in terms of how human activity increases contact with wildlife and thus zoonotic disease emergence, and discusses interventions that reduce such risk.
<a href="/items/browse?advanced%5B0%5D%5Belement_id%5D=39&advanced%5B0%5D%5Btype%5D=is+exactly&advanced%5B0%5D%5Bterms%5D=CDC%2C+Office+of+Public+Health+Preparedness+and+Response+%28CDC+OPHPR%29">CDC, Office of Public Health Preparedness and Response (CDC OPHPR)</a>
2017-11-02
2022-03-17 by Anna Yaffee (Adult Care Group) keep in Resource Library
2023-02-19 by Anna Yaffee T&C group Q1 review
2026-02-19
Refresher Training Agenda
<a href="/items/browse?advanced%5B0%5D%5Belement_id%5D=49&advanced%5B0%5D%5Btype%5D=is+exactly&advanced%5B0%5D%5Bterms%5D=Training+and+Exercises">Training and Exercises</a>
Leadership Toolbox, Response: Emory SCDU Refresher Training
<a href="/items/browse?advanced%5B0%5D%5Belement_id%5D=39&advanced%5B0%5D%5Btype%5D=is+exactly&advanced%5B0%5D%5Bterms%5D=Emory">Emory</a>
2018-01-25
2022-03-17 by Anna Yaffee (Adult Care Group) keep in RL SCDU relevant
2023-02-19 by Anna Yaffee T&C group Q1 review
Y - D0.1TE/D0.2TE Qualtrics # 417, original # 304
Y - D0.1TE/D0.2TE Qualtrics # 426, original # 316
Y - D0.1TE/D0.2TE Qualtrics # 428, original # 321
2026-02-19
Genomic Analysis of Lassa Virus during an Increase in Cases in Nigeria in 2018
<a href="/items/browse?advanced%5B0%5D%5Belement_id%5D=49&advanced%5B0%5D%5Btype%5D=is+exactly&advanced%5B0%5D%5Bterms%5D=Research">Research</a>
In early 2018 Nigeria experienced an unprecedented increase in Lassa fever cases with widespread geographic distribution.
<a href="/items/browse?advanced%5B0%5D%5Belement_id%5D=39&advanced%5B0%5D%5Btype%5D=is+exactly&advanced%5B0%5D%5Bterms%5D=Katherine+J.+Siddle%2C+Ph.D.%2C+Philomena+Eromon%2C+B.Sc.%2C+Kayla+G.+Barnes%2C+Ph.D.%2C+Judith+U.+Oguzie%2C+D.V.M.%2C+Samar+Mehta%2C+M.D.%2C+Ph.D.%2C+Ikponmwonsa+Odia%2C+M.Sc.%2C+Rickey+Shah%2C+A.L.M.%2C+Patrick+Brehio%2C+B.S.%2C+Sarah+M.+Winnicki%2C+M.S.%2C+Christopher+Iruolagbe%2C+M.B.B.S.%2C+John+Aiyepada%2C+B.Sc.%2C+Eghosa+Uyigue%2C+M.Sc.%2C+Patience+Akhilomen%2C+B.Sc.%2C+Grace+Okonofua%2C+B.Sc.%2C+Bridget+Chak%2C+B.A.%2C+Dylan+Kotliar%2C+B.A.%2C+Blessing+Osiemi%2C+B.Sc.%2C+Ekene+Muoebonam%2C+B.Sc.%2C+Michael+Airende%2C+B.Sc.%2C+Rachael+Ukpetina%2C+B.Sc.%2C+Iguosadolo+Nosamiefan%2C+A.B.%2C+Paul+Oluniyi%2C+M.Sc.%2C+Ephraim+Ogbaini-Emovon%2C+M.B.B.S.%2C+Mahan+Nekouin%2C+A.B.%2C+Onikepe+A.+Folarin%2C+Ph.D.%2C+Stephen+F.+Schaffner%2C+Ph.D.%2C+Robert+F.+Garry%2C+Ph.D.%2C+Kristian+G.+Andersen%2C+Ph.D.%2C+Daniel+J.+Park%2C+Ph.D.%2C+Nathan+L.+Yozwiak%2C+Ph.D.%2C+Bronwyn+L.+MacInnis%2C+Ph.D.%2C+George+Akpede%2C+M.B.B.S.%2C+Sylvanus+Okogbenin%2C+M.B.B.S.%2C+Peter+Okokhere%2C+M.B.B.S.%2C+Pardis+C.+Sabeti%2C+M.D.%2C+D.Phil.%2C+and+Christian+T.+Happi%2C+Ph.D.corresponding+author">Katherine J. Siddle, Ph.D., Philomena Eromon, B.Sc., Kayla G. Barnes, Ph.D., Judith U. Oguzie, D.V.M., Samar Mehta, M.D., Ph.D., Ikponmwonsa Odia, M.Sc., Rickey Shah, A.L.M., Patrick Brehio, B.S., Sarah M. Winnicki, M.S., Christopher Iruolagbe, M.B.B.S., John Aiyepada, B.Sc., Eghosa Uyigue, M.Sc., Patience Akhilomen, B.Sc., Grace Okonofua, B.Sc., Bridget Chak, B.A., Dylan Kotliar, B.A., Blessing Osiemi, B.Sc., Ekene Muoebonam, B.Sc., Michael Airende, B.Sc., Rachael Ukpetina, B.Sc., Iguosadolo Nosamiefan, A.B., Paul Oluniyi, M.Sc., Ephraim Ogbaini-Emovon, M.B.B.S., Mahan Nekouin, A.B., Onikepe A. Folarin, Ph.D., Stephen F. Schaffner, Ph.D., Robert F. Garry, Ph.D., Kristian G. Andersen, Ph.D., Daniel J. Park, Ph.D., Nathan L. Yozwiak, Ph.D., Bronwyn L. MacInnis, Ph.D., George Akpede, M.B.B.S., Sylvanus Okogbenin, M.B.B.S., Peter Okokhere, M.B.B.S., Pardis C. Sabeti, M.D., D.Phil., and Christian T. Happi, Ph.D.corresponding author</a>
2018-11-01
<a href="/items/browse?advanced%5B0%5D%5Belement_id%5D=51&advanced%5B0%5D%5Btype%5D=is+exactly&advanced%5B0%5D%5Bterms%5D=Publication">Publication</a>
Serosurvey on healthcare personnel caring for patients with Ebola virus disease and Lassa virus in the United States
<a href="/items/browse?advanced%5B0%5D%5Belement_id%5D=49&advanced%5B0%5D%5Btype%5D=is+exactly&advanced%5B0%5D%5Bterms%5D=Personnel+Management">Personnel Management</a>
Healthcare personnel (HCP) were recruited to provide serum samples, which were tested for antibodies against Ebola or Lassa virus to evaluate for asymptomatic seroconversion.
<a href="/items/browse?advanced%5B0%5D%5Belement_id%5D=39&advanced%5B0%5D%5Btype%5D=is+exactly&advanced%5B0%5D%5Bterms%5D=Kraft%2C+Colleen+S.%2C+Aneesh+K.+Mehta%2C+Jay+B.+Varkey%2C+G.+Marshall+Lyon%2C+Sharon+Vanairsdale%2C+Sonia+Bell%2C+Eileen+M.+Burd%2C+Mary+Elizabeth+Sexton%2C+Leslie+Anne+Cassidy%2C+Patricia+Olinger%2C+Kalpana+Rengarajan%2C+Vanessa+N.+Raabe%2C+Emily+Davis%2C+Scott+Henderson%2C+Paula+DesRoches%2C+Yongxian+Xu%2C+Mark+J.+Mulligan%2C+and+Bruce+S.+Ribner.">Kraft, Colleen S., Aneesh K. Mehta, Jay B. Varkey, G. Marshall Lyon, Sharon Vanairsdale, Sonia Bell, Eileen M. Burd, Mary Elizabeth Sexton, Leslie Anne Cassidy, Patricia Olinger, Kalpana Rengarajan, Vanessa N. Raabe, Emily Davis, Scott Henderson, Paula DesRoches, Yongxian Xu, Mark J. Mulligan, and Bruce S. Ribner.</a>
2020-04
2023-07-13 by Christa Arguinchona and Caroline Croyle (PM)
<a href="/items/browse?advanced%5B0%5D%5Belement_id%5D=51&advanced%5B0%5D%5Btype%5D=is+exactly&advanced%5B0%5D%5Bterms%5D=Publication">Publication</a>
2026-07-14
A Case of Human Lassa Virus Infection With Robust Acute T-Cell Activation and Long-Term Virus-Specific T-Cell Responses
<a href="/items/browse?advanced%5B0%5D%5Belement_id%5D=49&advanced%5B0%5D%5Btype%5D=is+exactly&advanced%5B0%5D%5Bterms%5D=Research">Research</a>
A nurse who acquired Lassa virus infection in Togo in the spring of 2016 was repatriated to the United States for care at Emory University Hospital.
<a href="/items/browse?advanced%5B0%5D%5Belement_id%5D=39&advanced%5B0%5D%5Btype%5D=is+exactly&advanced%5B0%5D%5Bterms%5D=McElroy%2C+A.+K.%2C+R.+S.+Akondy%2C+J.+R.+Harmon%2C+A.+H.+Ellebedy%2C+D.+Cannon%2C+J.+D.+Klena%2C+J.+Sidney%2C+A.+Sette%2C+A.+K.+Mehta%2C+C.+S.+Kraft%2C+M.+G.+Lyon%2C+J.+B.+Varkey%2C+B.+S.+Ribner%2C+S.+T.+Nichol+and+C.+F.+Spiropoulou">McElroy, A. K., R. S. Akondy, J. R. Harmon, A. H. Ellebedy, D. Cannon, J. D. Klena, J. Sidney, A. Sette, A. K. Mehta, C. S. Kraft, M. G. Lyon, J. B. Varkey, B. S. Ribner, S. T. Nichol and C. F. Spiropoulou</a>
2017-06-15
<a href="/items/browse?advanced%5B0%5D%5Belement_id%5D=51&advanced%5B0%5D%5Btype%5D=is+exactly&advanced%5B0%5D%5Bterms%5D=Publication">Publication</a>
NETEC COVID-19 Webinar Series (4/1/22)/Online Course: Identify, Isolate, Inform. The I's have it.
<a href="/items/browse?advanced%5B0%5D%5Belement_id%5D=49&advanced%5B0%5D%5Btype%5D=is+exactly&advanced%5B0%5D%5Bterms%5D=Infection+Control">Infection Control</a>
Identify, Isolate, Inform - The I's Have It!<br /><br />NETEC webinar presentation: Identify, Isolate, Inform. The I's Have It. Topics will include the importance of early recognition in identifying individuals potentially infected with a special pathogen, steps that can be taken to reduce special pathogen exposure to others and the environment, and tips on organizing a notification system applicable to both a home institution and the public health system.<br /><br /><br />PRESENTERS<br /><br />Kate Boulter, BAN (HONS), MPH, RN<br />Nurse Manager Nebraska Biocontainment Unit<br />Nebraska Medicine | University of Nebraska Medical Center, Omaha, Nebraska<br /><br />Dr. James Lawler, MD, MPH, FIDSA<br />Associate Professor, Department of Internal Medicine<br />Director, International Programs and Innovation, Global Center for Health Security<br />Director, Clinical and Biodefense Research<br />Nebraska Medicine | University of Nebraska Medical Center, Omaha, Nebraska<br /><br />Trish Tennill, RN, BSN<br />Associative Director of Nursing<br />Health and Hospitals Bellevue New York, New York<br /><br />Webinar slides attached.<br /><br /><br />
<h2><br />Get educational credit for this webinar through <a href="https://courses.netec.org/courses/identify-isolate-inform-the-is-have-it" target="_blank" title="CEU link" rel="noreferrer noopener">Courses.netec.org</a>.</h2>
<a href="/items/browse?advanced%5B0%5D%5Belement_id%5D=39&advanced%5B0%5D%5Btype%5D=is+exactly&advanced%5B0%5D%5Bterms%5D=NETEC">NETEC</a>
2022-04-01
2024-03-27 IIT - haven't gotten back first review - bump to next quarter
Y - D0.1IIT/D0.2IIT Qualtrics # 704
Y - D0.1IIT/D0.2IIT Qualtrics # 705
Y - D0.1IIT/D0.2IIT Qualtrics # 707
Y - D0.1IIT/D0.2IIT Qualtrics # 716
<a href="/items/browse?advanced%5B0%5D%5Belement_id%5D=51&advanced%5B0%5D%5Btype%5D=is+exactly&advanced%5B0%5D%5Bterms%5D=Webinar+and+Online+Course">Webinar and Online Course</a>
2024-06-27
Laboratory Resources: Lassa Fever
<a href="/items/browse?advanced%5B0%5D%5Belement_id%5D=49&advanced%5B0%5D%5Btype%5D=is+exactly&advanced%5B0%5D%5Bterms%5D=Laboratory">Laboratory</a>
This guide, printable flyer, provides laboratory resources related to Lassa Fever. This is a part of a series of one-page resource guides for laboratorians.
<a href="/items/browse?advanced%5B0%5D%5Belement_id%5D=39&advanced%5B0%5D%5Btype%5D=is+exactly&advanced%5B0%5D%5Bterms%5D=NETEC">NETEC</a>
2022-05-17
2022-09-27 - general asset review - Treatment & Care group
2025-05-17
A Clinicians Reference Guide to Lassa Virus
<a href="/items/browse?advanced%5B0%5D%5Belement_id%5D=49&advanced%5B0%5D%5Btype%5D=is+exactly&advanced%5B0%5D%5Bterms%5D=Treatment+%26+Care">Treatment & Care</a>
This blog post provides a Clinical Perspective on Lassa Virus from NETEC experts.
<a href="/items/browse?advanced%5B0%5D%5Belement_id%5D=39&advanced%5B0%5D%5Btype%5D=is+exactly&advanced%5B0%5D%5Bterms%5D=NETEC">NETEC</a>
2022-06-30
2023-07-10
Lassa Fever: Testing and Treatments
<a href="/items/browse?advanced%5B0%5D%5Belement_id%5D=49&advanced%5B0%5D%5Btype%5D=is+exactly&advanced%5B0%5D%5Bterms%5D=Treatment+%26+Care">Treatment & Care</a>
Lassa virus infection can result in a broad spectrum of clinical signs and symptoms, from asymptomatic or very minimal symptoms to the severe manifestation, a viral hemorrhagic fever. In addition, the early symptoms of Lassa fever are similar in nature to those of other common viral illnesses, including influenza, which makes it difficult for clinicians to identify early on.<br /><br />This blog post covers information on diagnosing, testing for, and treating Lassa.
<a href="/items/browse?advanced%5B0%5D%5Belement_id%5D=39&advanced%5B0%5D%5Btype%5D=is+exactly&advanced%5B0%5D%5Bterms%5D=NETEC">NETEC</a>
2022-06-29
2023-07-10
Preventing Lassa Virus Infections in Health Care Settings
<a href="/items/browse?advanced%5B0%5D%5Belement_id%5D=49&advanced%5B0%5D%5Btype%5D=is+exactly&advanced%5B0%5D%5Bterms%5D=Infection+Control">Infection Control</a>
This blog post covers information on stopping transmission of Lassa Fever with Infection Prevention and Control and Waste Management.
<a href="/items/browse?advanced%5B0%5D%5Belement_id%5D=39&advanced%5B0%5D%5Btype%5D=is+exactly&advanced%5B0%5D%5Bterms%5D=NETEC">NETEC</a>
2022-06-21
2023-07-13 by Christa Arguinchona and Caroline Croyle (PM) - Created in 2022, recommending checking in every 2 years unless significant changes to lassa fever recs
Y - D0.1PM/D0.2PM Qualtrics # 904, original # 3
2025-07-20
Lassa Fever: Biocontainment and PPE for Patient Care
<a href="/items/browse?advanced%5B0%5D%5Belement_id%5D=49&advanced%5B0%5D%5Btype%5D=is+exactly&advanced%5B0%5D%5Bterms%5D=Infection+Control">Infection Control</a>
This blog post covers infection control, biocontainment, PPE, and related topics for Lassa Fever patients. <br /><br />Because of the high degree of mortality associated with infection, patients infected with or suspected to be infected with Lassa virus should be cared for in a biocontainment unit and health care providers should follow personal protective equipment (PPE) guidance to prevent secondary person-to-person spread.
<a href="/items/browse?advanced%5B0%5D%5Belement_id%5D=39&advanced%5B0%5D%5Btype%5D=is+exactly&advanced%5B0%5D%5Bterms%5D=NETEC">NETEC</a>
2022-06-13
Infection Prevention and Control; PPE
2023-07-20
Lassa Fever: What You Need to Know as Outbreaks Continue
<a href="/items/browse?advanced%5B0%5D%5Belement_id%5D=49&advanced%5B0%5D%5Btype%5D=is+exactly&advanced%5B0%5D%5Bterms%5D=General">General</a>
This blog post covers the basics of what you need to know about Lassa Fever: Transmission, Symptoms, and Signs.<br /><br />Lassa fever is an animal-borne, or zoonotic, acute viral hemorrhagic illness endemic in parts of West Africa including Sierra Leone, Liberia, Guinea, and Nigeria. Neighboring countries are also at risk, as the animal vector for Lassa virus, the “multimammate rat” (Mastomys natalensis) is distributed throughout the region (<a href="https://www.cdc.gov/vhf/lassa/index.html" target="_blank" rel="noreferrer noopener">CDC</a>).
<a href="/items/browse?advanced%5B0%5D%5Belement_id%5D=39&advanced%5B0%5D%5Btype%5D=is+exactly&advanced%5B0%5D%5Bterms%5D=NETEC">NETEC</a>
2022-06-06
2023-07-20
Lassa Fever: a Summary for Clinicians
<a href="/items/browse?advanced%5B0%5D%5Belement_id%5D=49&advanced%5B0%5D%5Btype%5D=is+exactly&advanced%5B0%5D%5Bterms%5D=Treatment+%26+Care">Treatment & Care</a>
On this episode of Transmission Interrupted, we welcome Dr. Jared Evans, Dr. Aneesh Mehta, and Dr. Vanessa Rabbe—members of NETEC’s Special Pathogen Research Network—to discuss their recent manuscript entitled, “Lassa Virus Infection: a Summary for Clinicians.” Developed from a clinical perspective, this manuscript provides clinicians with a condensed, accessible understanding of the current literature on Lassa virus (LASV) infection and Lassa fever disease (LF). The topics discussed in this episode will provide basic information on Lassa virus and Lassa fever, and will highlight pathogenesis, clinical features, and medical countermeasures that have demonstrated potential value for use in clinical or research environments.
<a href="/items/browse?advanced%5B0%5D%5Belement_id%5D=39&advanced%5B0%5D%5Btype%5D=is+exactly&advanced%5B0%5D%5Bterms%5D=NETEC">NETEC</a>
2022-06-29
2023-07-20
Viral Hemorrhagic Fevers (VHFs) Matrix
<a href="/items/browse?advanced%5B0%5D%5Belement_id%5D=49&advanced%5B0%5D%5Btype%5D=is+exactly&advanced%5B0%5D%5Bterms%5D=Infection+Control">Infection Control</a>
This group of infectious diseases is caused by several distinct viral families. The term VHF describes the conditions these pathogens can cause, which may affect many body systems, including damaging the cardiovascular system. Some of these viruses produce mild disease, while others can interfere with blood clotting, cause severe disease, and death.<br /><br />This document provides information Personal Protective Equipment and Precautions, and PPE selection for Viral Hemorrhagic Fevers.
<a href="/items/browse?advanced%5B0%5D%5Belement_id%5D=39&advanced%5B0%5D%5Btype%5D=is+exactly&advanced%5B0%5D%5Bterms%5D=NETEC">NETEC</a>
2023-06-22
2024-06-22
Health Care Facility Viral Hemorrhagic Fever (VHF) Preparedness Checklist
<a href="/items/browse?advanced%5B0%5D%5Belement_id%5D=49&advanced%5B0%5D%5Btype%5D=is+exactly&advanced%5B0%5D%5Bterms%5D=Emergency+Management">Emergency Management</a>
<p>Viral Hemorrhagic Fevers (VHF) are a group of diseases caused by several families of viruses. The term VHF refers to an illness that can affect multiple organ systems and can be accompanied by fever, headache, vomiting, abdominal pain, diarrhea, and hemorrhage. VHFs addressed in this document include <strong>Crimean-Congo Hemorrhagic Fever (CCHF)</strong>, <strong>Ebola Virus Disease (EVD)</strong>, <strong>Lassa Fever</strong>, and <strong>Marburg Virus Disease (MVD)</strong>.<br /><br />All health care facilities are part of the frontline defense against the spread of disease, as patients will seek care in emergency departments, urgent care centers and clinics. Health care facility preparedness to care for patients with a VHF is essential to prevent transmission to staff, other patients, and our communities.<br /><br />NETEC developed the Health Care Facility Viral Hemorrhagic Fever Preparedness Checklist to help health care facilities assess their readiness to identify, isolate, inform, and provide initial treatment for patients suspected or confirmed to have a VHF. This checklist is intended to guide facilities through a review of their immediate care capabilities and provide resources to assist in the resolution of preparedness gaps it reveals.</p>
<p><strong>Subscribe to the NETEC e-newsletter highlighting courses and training events, educational resources and information, and research news. <a target="_blank" href="https://netec.org/newsletter-sign-up/" rel="noreferrer noopener">Subscribe here.</a></strong></p>
<a href="/items/browse?advanced%5B0%5D%5Belement_id%5D=39&advanced%5B0%5D%5Btype%5D=is+exactly&advanced%5B0%5D%5Bterms%5D=NETEC">NETEC</a>
2023-04-18
Not yet reviewed new - IPC
2024-04-18
Considerations for Terminal Cleaning and Decontamination of Special Pathogen Patient Care Rooms
<a href="/items/browse?advanced%5B0%5D%5Belement_id%5D=49&advanced%5B0%5D%5Btype%5D=is+exactly&advanced%5B0%5D%5Bterms%5D=Infection+Control">Infection Control</a>
Purpose: The information in this document includes general considerations that may be incorporated into terminal cleaning plans. It is intended to serve as a planning tool and resource for risk assessments or preparedness activities.
<a href="/items/browse?advanced%5B0%5D%5Belement_id%5D=39&advanced%5B0%5D%5Btype%5D=is+exactly&advanced%5B0%5D%5Bterms%5D=NETEC">NETEC</a>
The Infection Prevention and Control Work Group
2023-04-17
Y<br />Y - D0.1IC/D0.2IC Qualtrics # 201, original # 1<br />Y - D0.1IC/D0.2IC Qualtrics # 202, original # 1a<br />Y - D0.1IC/D0.2IC Qualtrics # 203, original # 1b<br />
<table style="border-collapse:collapse;width:490.328px;">
<tbody>
<tr>
<td style="width:44.1562px;white-space:normal;height:39px;background-color:transparent;border:1px solid #ababab;"><b>POS</b></td>
<td style="width:63.1484px;height:39px;white-space:normal;background-color:transparent;border:1px solid #ababab;"><b>DOMAIN</b></td>
<td style="width:76.9922px;white-space:normal;height:39px;background-color:transparent;border:1px solid #ababab;"><b>Original Question #</b></td>
<td style="width:73.0312px;white-space:normal;height:39px;background-color:transparent;border:1px solid #ababab;"><b>Qualtrics #</b></td>
<td style="width:232px;white-space:normal;height:39px;background-color:transparent;border:1px solid #ababab;"><b>Asset Link</b></td>
</tr>
<tr>
<td style="width:44.1562px;height:25.7891px;white-space:normal;background-color:transparent;border:1px solid #ababab;">45</td>
<td style="width:63.1484px;white-space:normal;background-color:transparent;border:1px solid #ababab;">2</td>
<td style="width:76.9922px;white-space:normal;background-color:transparent;border:1px solid #ababab;">1</td>
<td style="width:73.0312px;white-space:normal;background-color:transparent;border:1px solid #ababab;">201</td>
<td style="width:232px;white-space:normal;background-color:transparent;border:1px solid #ababab;">Considerations for Terminal Cleaning</td>
</tr>
<tr>
<td style="width:44.1562px;height:21.9609px;white-space:normal;background-color:transparent;border:1px solid #ababab;">46</td>
<td style="width:63.1484px;height:21.9609px;white-space:normal;background-color:transparent;border:1px solid #ababab;">2</td>
<td style="width:76.9922px;height:21.9609px;white-space:normal;background-color:transparent;border:1px solid #ababab;">1a</td>
<td style="width:73.0312px;height:21.9609px;white-space:normal;background-color:transparent;border:1px solid #ababab;">202</td>
<td style="width:232px;height:21.9609px;white-space:normal;background-color:transparent;border:1px solid #ababab;"><span class="x_ContentPasted1" style="background-color:#ffffff;">Considerations for Terminal Cleaning</span></td>
</tr>
<tr>
<td style="width:44.1562px;height:21.9609px;white-space:normal;background-color:transparent;border:1px solid #ababab;">47</td>
<td style="width:63.1484px;height:21.9609px;white-space:normal;background-color:transparent;border:1px solid #ababab;">2</td>
<td style="width:76.9922px;height:21.9609px;white-space:normal;background-color:transparent;border:1px solid #ababab;">1b</td>
<td style="width:73.0312px;height:21.9609px;white-space:normal;background-color:transparent;border:1px solid #ababab;">203</td>
<td style="width:232px;height:21.9609px;white-space:normal;background-color:transparent;border:1px solid #ababab;"><span class="x_ContentPasted2" style="background-color:#ffffff;">Considerations for Terminal Cleaning</span></td>
</tr>
</tbody>
</table>
<table style="border-collapse:collapse;width:490.328px;">
<tbody>
<tr>
<td style="width:44.1562px;height:21.9609px;white-space:normal;background-color:transparent;border:1px solid #ababab;">56</td>
<td style="width:63.1484px;white-space:normal;height:21.9609px;background-color:transparent;border:1px solid #ababab;">2</td>
<td style="width:76.9922px;height:21.9609px;white-space:normal;background-color:transparent;border:1px solid #ababab;">6</td>
<td style="width:73.0312px;white-space:normal;height:21.9609px;background-color:transparent;border:1px solid #ababab;">211</td>
<td style="width:232px;height:21.9609px;white-space:normal;border:1px solid #ababab;"><span class="x_ContentPasted3" style="margin:0px;background-color:#ffffff;">Considerations for Terminal Cleaning</span></td>
</tr>
<tr>
<td style="width:44.1562px;height:21.9609px;white-space:normal;background-color:transparent;border:1px solid #ababab;">58</td>
<td style="width:63.1484px;white-space:normal;height:21.9609px;background-color:transparent;border:1px solid #ababab;">2</td>
<td style="width:76.9922px;height:21.9609px;white-space:normal;background-color:transparent;border:1px solid #ababab;">6a</td>
<td style="width:73.0312px;white-space:normal;height:21.9609px;background-color:transparent;border:1px solid #ababab;">212</td>
<td style="width:232px;height:21.9609px;white-space:normal;border:1px solid #ababab;"><span class="x_ContentPasted3" style="margin:0px;background-color:#ffffff;">Considerations for Terminal Cleaning</span></td>
</tr>
<tr>
<td style="width:44.1562px;height:21.9609px;white-space:normal;background-color:transparent;border:1px solid #ababab;">61</td>
<td style="width:63.1484px;white-space:normal;height:21.9609px;background-color:transparent;border:1px solid #ababab;">2</td>
<td style="width:76.9922px;height:21.9609px;white-space:normal;background-color:transparent;border:1px solid #ababab;">8</td>
<td style="width:73.0312px;white-space:normal;height:21.9609px;background-color:transparent;border:1px solid #ababab;">215</td>
<td style="width:232px;height:21.9609px;white-space:normal;border:1px solid #ababab;">Considerations for Terminal Cleaning</td>
</tr>
<tr>
<td style="width:44.1562px;height:21.9609px;white-space:normal;background-color:transparent;border:1px solid #ababab;">62</td>
<td style="width:63.1484px;white-space:normal;height:21.9609px;background-color:transparent;border:1px solid #ababab;">2</td>
<td style="width:76.9922px;white-space:normal;height:21.9609px;background-color:transparent;border:1px solid #ababab;">8a</td>
<td style="width:73.0312px;white-space:normal;height:21.9609px;background-color:transparent;border:1px solid #ababab;">216</td>
<td style="width:232px;height:21.9609px;white-space:normal;border:1px solid #ababab;">Considerations for Terminal Cleaning</td>
</tr>
<tr>
<td style="width:44.1562px;height:21.9609px;white-space:normal;background-color:transparent;border:1px solid #ababab;">64</td>
<td style="width:63.1484px;height:21.9609px;white-space:normal;background-color:transparent;border:1px solid #ababab;">2</td>
<td style="width:76.9922px;height:21.9609px;white-space:normal;background-color:transparent;border:1px solid #ababab;">9</td>
<td style="width:73.0312px;height:21.9609px;white-space:normal;background-color:transparent;border:1px solid #ababab;">218</td>
<td style="width:232px;height:21.9609px;white-space:normal;background-color:transparent;border:1px solid #ababab;">Considerations for Terminal Cleaning</td>
</tr>
<tr>
<td style="width:44.1562px;height:23.0078px;white-space:normal;background-color:transparent;border:1px solid #ababab;">66</td>
<td style="width:63.1484px;white-space:normal;height:23.0078px;background-color:transparent;border:1px solid #ababab;">2</td>
<td style="width:76.9922px;white-space:normal;height:23.0078px;background-color:transparent;border:1px solid #ababab;">9b</td>
<td style="width:73.0312px;white-space:normal;height:23.0078px;background-color:transparent;border:1px solid #ababab;">220</td>
<td style="width:232px;height:23.0078px;white-space:normal;background-color:transparent;border:1px solid #ababab;">Considerations for Terminal Cleaning</td>
</tr>
<tr>
<td style="width:44.1562px;height:21.9609px;white-space:normal;background-color:transparent;border:1px solid #ababab;">67</td>
<td style="width:63.1484px;height:21.9609px;white-space:normal;background-color:transparent;border:1px solid #ababab;">2</td>
<td style="width:76.9922px;height:21.9609px;white-space:normal;background-color:transparent;border:1px solid #ababab;">9c</td>
<td style="width:73.0312px;height:21.9609px;white-space:normal;background-color:transparent;border:1px solid #ababab;">221</td>
<td style="width:232px;height:21.9609px;white-space:normal;background-color:transparent;border:1px solid #ababab;"><span class="x_ContentPasted5" style="background-color:#ffffff;">Considerations for Terminal Cleaning</span></td>
</tr>
<tr>
<td style="width:44.1562px;height:21.9609px;white-space:normal;background-color:transparent;border:1px solid #ababab;">68</td>
<td style="width:63.1484px;height:21.9609px;white-space:normal;background-color:transparent;border:1px solid #ababab;">2</td>
<td style="width:76.9922px;height:21.9609px;white-space:normal;background-color:transparent;border:1px solid #ababab;">10</td>
<td style="width:73.0312px;height:21.9609px;white-space:normal;background-color:transparent;border:1px solid #ababab;">222</td>
<td style="width:232px;height:21.9609px;white-space:normal;background-color:transparent;border:1px solid #ababab;"><span class="x_ContentPasted6" style="background-color:#ffffff;">Considerations for Terminal Cleaning</span></td>
</tr>
<tr>
<td style="width:44.1562px;height:21.9609px;white-space:normal;background-color:transparent;border:1px solid #ababab;">69</td>
<td style="width:63.1484px;height:21.9609px;white-space:normal;background-color:transparent;border:1px solid #ababab;">2</td>
<td style="width:76.9922px;height:21.9609px;white-space:normal;background-color:transparent;border:1px solid #ababab;">11</td>
<td style="width:73.0312px;height:21.9609px;white-space:normal;background-color:transparent;border:1px solid #ababab;">223</td>
<td style="width:232px;height:21.9609px;white-space:normal;background-color:transparent;border:1px solid #ababab;"><span class="x_ContentPasted7" style="background-color:#ffffff;">Considerations for Terminal Cleaning</span></td>
</tr>
<tr>
<td style="width:44.1562px;height:21.9609px;white-space:normal;background-color:transparent;border:1px solid #ababab;">72</td>
<td style="width:63.1484px;height:21.9609px;white-space:normal;background-color:transparent;border:1px solid #ababab;">2</td>
<td style="width:76.9922px;height:21.9609px;white-space:normal;background-color:transparent;border:1px solid #ababab;">13</td>
<td style="width:73.0312px;height:21.9609px;white-space:normal;background-color:transparent;border:1px solid #ababab;">226</td>
<td style="width:232px;height:21.9609px;white-space:normal;background-color:transparent;border:1px solid #ababab;"><span class="x_ContentPasted8" style="background-color:#ffffff;">Considerations for Terminal Cleaning</span></td>
</tr>
<tr>
<td style="width:44.1562px;height:21.9609px;white-space:normal;background-color:transparent;border:1px solid #ababab;">73</td>
<td style="width:63.1484px;height:21.9609px;white-space:normal;background-color:transparent;border:1px solid #ababab;">2</td>
<td style="width:76.9922px;height:21.9609px;white-space:normal;background-color:transparent;border:1px solid #ababab;">14</td>
<td style="width:73.0312px;height:21.9609px;white-space:normal;background-color:transparent;border:1px solid #ababab;">227</td>
<td style="width:232px;height:21.9609px;white-space:normal;background-color:transparent;border:1px solid #ababab;"><span class="x_ContentPasted9" style="background-color:#ffffff;">Considerations for Terminal Cleaning</span></td>
</tr>
<tr>
<td style="width:44.1562px;height:21.9609px;white-space:normal;background-color:transparent;border:1px solid #ababab;">74</td>
<td style="width:63.1484px;height:21.9609px;white-space:normal;background-color:transparent;border:1px solid #ababab;">2</td>
<td style="width:76.9922px;height:21.9609px;white-space:normal;background-color:transparent;border:1px solid #ababab;">15</td>
<td style="width:73.0312px;height:21.9609px;white-space:normal;background-color:transparent;border:1px solid #ababab;">228</td>
<td style="width:232px;height:21.9609px;white-space:normal;background-color:transparent;border:1px solid #ababab;"><span class="x_ContentPasted10" style="background-color:#ffffff;">Considerations for Terminal Cleaning</span></td>
</tr>
<tr>
<td style="width:44.1562px;height:21.9609px;white-space:normal;background-color:transparent;border:1px solid #ababab;">75</td>
<td style="width:63.1484px;height:21.9609px;white-space:normal;background-color:transparent;border:1px solid #ababab;">2</td>
<td style="width:76.9922px;height:21.9609px;white-space:normal;background-color:transparent;border:1px solid #ababab;">16</td>
<td style="width:73.0312px;height:21.9609px;white-space:normal;background-color:transparent;border:1px solid #ababab;">229</td>
<td style="width:232px;height:21.9609px;white-space:normal;background-color:transparent;border:1px solid #ababab;"><span class="x_ContentPasted11" style="background-color:#ffffff;">Considerations for Terminal Cleaning</span></td>
</tr>
<tr>
<td style="width:44.1562px;height:22.0391px;white-space:normal;background-color:transparent;border:1px solid #ababab;">76</td>
<td style="width:63.1484px;height:22.0391px;white-space:normal;background-color:transparent;border:1px solid #ababab;">2</td>
<td style="width:76.9922px;height:22.0391px;white-space:normal;background-color:transparent;border:1px solid #ababab;">17</td>
<td style="width:73.0312px;height:22.0391px;white-space:normal;background-color:transparent;border:1px solid #ababab;">230</td>
<td style="width:232px;height:22.0391px;white-space:normal;background-color:transparent;border:1px solid #ababab;"><span class="x_ContentPasted12" style="background-color:#ffffff;">Considerations for Terminal Cleaning</span></td>
</tr>
</tbody>
</table>
2025-04-17
Nextstrain - Real-time tracking of Lassa virus evolution 2015-2018 Outbreak in Nigeria
<a href="/items/browse?advanced%5B0%5D%5Belement_id%5D=49&advanced%5B0%5D%5Btype%5D=is+exactly&advanced%5B0%5D%5Bterms%5D=General">General</a>
Nextstrain is an open-source project to harness the scientific and public health potential of pathogen genome data. It provides a continually-updated view of publicly available data alongside powerful analytic and visualization tools for use by the community. The goal is to aid epidemiological understanding and improve outbreak response. <iframe width="100%" height="500" title="Nextstrain Lassa" src="https://nextstrain.org/community/pauloluniyi/lassa/l"></iframe>
<a href="/items/browse?advanced%5B0%5D%5Belement_id%5D=39&advanced%5B0%5D%5Btype%5D=is+exactly&advanced%5B0%5D%5Bterms%5D=Nextstrain">Nextstrain</a>
Built with <a href="https://github.com/pauloluniyi/lassa" target="_blank" class="byline__BylineLink-sc-wamdqn-1 MujGV" rel="noreferrer noopener">pauloluniyi/lassa</a>. Maintained by Paul Oluniyi, ACEGID Redeemer's University.
2018-08-07
Antibodies Against Ebola and Lassa
<a href="/items/browse?advanced%5B0%5D%5Belement_id%5D=49&advanced%5B0%5D%5Btype%5D=is+exactly&advanced%5B0%5D%5Bterms%5D=Research">Research</a>
The 2017 Kinyoun Lecture discusses antibodies protecting against Ebola and Lassa, and the need for research collaboration.
<a href="/items/browse?advanced%5B0%5D%5Belement_id%5D=39&advanced%5B0%5D%5Btype%5D=is+exactly&advanced%5B0%5D%5Bterms%5D=NIH">NIH</a>
2017-12-05
NYC Health + Hospitals Special Pathogens Response Matrix
<a href="/items/browse?advanced%5B0%5D%5Belement_id%5D=49&advanced%5B0%5D%5Btype%5D=is+exactly&advanced%5B0%5D%5Bterms%5D=Emergency+Management">Emergency Management</a>
Matrix with response to different special pathogens.
<a href="/items/browse?advanced%5B0%5D%5Belement_id%5D=39&advanced%5B0%5D%5Btype%5D=is+exactly&advanced%5B0%5D%5Bterms%5D=NYC+Health+%2B+Hospitals">NYC Health + Hospitals</a>
2023-12-15
2023-12-15 by Darrell Ruby and Amy Mead/EM WG - recommended update MPox section. Syra Madad submitted updated version.
Y - D0.1EM/D0.2EM - Qualtrics # 505
2025-12-15
Favipiravir and Ribavirin Treatment of Epidemiologically Linked Cases of Lassa Fever
<a href="/items/browse?advanced%5B0%5D%5Belement_id%5D=49&advanced%5B0%5D%5Btype%5D=is+exactly&advanced%5B0%5D%5Bterms%5D=Treatment+%26+Care">Treatment & Care</a>
Two patients with Lassa fever are described who are the first human cases treated with a combination of ribavirin and favipiravir.
<a href="/items/browse?advanced%5B0%5D%5Belement_id%5D=39&advanced%5B0%5D%5Btype%5D=is+exactly&advanced%5B0%5D%5Bterms%5D=Raabe%2C+V.+N.%2C+G.+Kann%2C+B.+S.+Ribner%2C+A.+Morales%2C+J.+B.+Varkey%2C+A.+K.+Mehta%2C+G.+M.+Lyon%2C+S.+Vanairsdale%2C+K.+Faber%2C+S.+Becker%2C+M.+Eickmann%2C+T.+Strecker%2C+S.+Brown%2C+K.+Patel%2C+P.+De+Leuw%2C+G.+Schuettfort%2C+C.+Stephan%2C+H.+Rabenau%2C+J.+D.+Klena%2C+P.+E.+Rollin%2C+A.+McElroy%2C+U.+Stroher%2C+S.+Nichol%2C+C.+S.+Kraft%2C+T.+Wolf+and+U.+Emory+Serious+Communicable+Diseases">Raabe, V. N., G. Kann, B. S. Ribner, A. Morales, J. B. Varkey, A. K. Mehta, G. M. Lyon, S. Vanairsdale, K. Faber, S. Becker, M. Eickmann, T. Strecker, S. Brown, K. Patel, P. De Leuw, G. Schuettfort, C. Stephan, H. Rabenau, J. D. Klena, P. E. Rollin, A. McElroy, U. Stroher, S. Nichol, C. S. Kraft, T. Wolf and U. Emory Serious Communicable Diseases</a>
2017-09-01
2022-09-27 - general asset review - Treatment & Care group
<a href="/items/browse?advanced%5B0%5D%5Belement_id%5D=51&advanced%5B0%5D%5Btype%5D=is+exactly&advanced%5B0%5D%5Bterms%5D=Publication">Publication</a>
2024-09-27
Lassa Virus Infection: a Summary for Clinicians
<a href="/items/browse?advanced%5B0%5D%5Belement_id%5D=49&advanced%5B0%5D%5Btype%5D=is+exactly&advanced%5B0%5D%5Bterms%5D=General">General</a>
This summary on Lassa virus (LASV) infection and Lassa fever disease (LF) was developed from a clinical perspective to provide clinicians with a condensed, accessible understanding of the current literature. The information provided highlights pathogenesis, clinical features, and diagnostics emphasizing therapies and vaccines that have demonstrated potential value for use in clinical or research environments.
<a href="/items/browse?advanced%5B0%5D%5Belement_id%5D=39&advanced%5B0%5D%5Btype%5D=is+exactly&advanced%5B0%5D%5Bterms%5D=Science+Working+Group+of+the+National+Emerging+Special+Pathogens+Training+and+Education+Center+%28NETEC%29+Special+Pathogens+Research+Network+%28SPRN%29">Science Working Group of the National Emerging Special Pathogens Training and Education Center (NETEC) Special Pathogens Research Network (SPRN)</a>
Vanessa Raabe, Aneesh K Mehta, Jared D Evans
2022-04-05
<a href="/items/browse?advanced%5B0%5D%5Belement_id%5D=51&advanced%5B0%5D%5Btype%5D=is+exactly&advanced%5B0%5D%5Bterms%5D=Publication">Publication</a>
2023-07-25
Factors associated with progression to death in patients with Lassa fever in Nigeria: an observational study
<a href="/items/browse?advanced%5B0%5D%5Belement_id%5D=49&advanced%5B0%5D%5Btype%5D=is+exactly&advanced%5B0%5D%5Bterms%5D=Research">Research</a>
Lassa fever is endemic in several west African countries. Case-fatality rates ranging from 21% to 69% have been reported. The pathophysiology of the disease in humans and determinants of mortality remain poorly understood. We aimed to determine host protein biomarkers capable of determining disease outcome.
<a href="/items/browse?advanced%5B0%5D%5Belement_id%5D=39&advanced%5B0%5D%5Btype%5D=is+exactly&advanced%5B0%5D%5Bterms%5D=Strampe%2C+Jamie%2C+Danny+A.+Asogun%2C+Emily+Speranza%2C+Meike+Pahlmann%2C+Ali+Soucy%2C+Sabrina+Bockholt%2C+Elisa+Pallasch%2C+Beate+Becker-Ziaja%2C+Sophie+Duraffour%2C+Nahid+Bhadelia%2C+Yemisi+Ighodalo%2C+Jennifer+Oyakhilome%2C+Emmanuel+O.+Omomoh%2C+Thomas+Olokor%2C+Donatus+I.+Adomeh%2C+Odia+Ikponwonsa%2C+Chris+Aire%2C+Ekaete+Tobin%2C+Nosa+Akpede%2C+Peter+O.+Okokhere%2C+Sylvanus+A.+Okogbenin%2C+George+O.+Akpede%2C+C%C3%A9sar+Mu%C3%B1oz-Fontela%2C+Ephraim+Ogbaini-Emovon%2C+Stephan+G%C3%BCnther%2C+John+H.+Connor%2C+and+Lisa+Oestereich.">Strampe, Jamie, Danny A. Asogun, Emily Speranza, Meike Pahlmann, Ali Soucy, Sabrina Bockholt, Elisa Pallasch, Beate Becker-Ziaja, Sophie Duraffour, Nahid Bhadelia, Yemisi Ighodalo, Jennifer Oyakhilome, Emmanuel O. Omomoh, Thomas Olokor, Donatus I. Adomeh, Odia Ikponwonsa, Chris Aire, Ekaete Tobin, Nosa Akpede, Peter O. Okokhere, Sylvanus A. Okogbenin, George O. Akpede, César Muñoz-Fontela, Ephraim Ogbaini-Emovon, Stephan Günther, John H. Connor, and Lisa Oestereich.</a>
2021-01-20
<a href="/items/browse?advanced%5B0%5D%5Belement_id%5D=51&advanced%5B0%5D%5Btype%5D=is+exactly&advanced%5B0%5D%5Bterms%5D=Publication">Publication</a>
Viral Hemorrhagic Fever (VHF) or Orthopox Virus ~ ED Screening
<a href="/items/browse?advanced%5B0%5D%5Belement_id%5D=49&advanced%5B0%5D%5Btype%5D=is+exactly&advanced%5B0%5D%5Bterms%5D=Infection+Control">Infection Control</a>
Viral Hemorrhagic Fever or Orthopox Virus Emergency Department Screening
<a href="/items/browse?advanced%5B0%5D%5Belement_id%5D=39&advanced%5B0%5D%5Btype%5D=is+exactly&advanced%5B0%5D%5Bterms%5D=University+of+Nebraska+Medical+Center+%2F+Nebraska+Medicine">University of Nebraska Medical Center / Nebraska Medicine</a>
2022-03-15
2022-03-17 by Shelly Schwedhelm (to be added)
2023-09-24
Lassa fever: Introduction
<a href="/items/browse?advanced%5B0%5D%5Belement_id%5D=49&advanced%5B0%5D%5Btype%5D=is+exactly&advanced%5B0%5D%5Bterms%5D=Training+and+Exercises">Training and Exercises</a>
Lassa fever, a viral haemorrhagic fever with symptoms similar to those of Ebola virus disease, is endemic in much of West Africa and usually sparks a seasonal outbreak from December to March. Humans usually become infected with Lassa virus from exposure to urine and faeces of infected Mastomys rats. Lassa virus may also be spread between humans through direct contact with the blood, urine, faeces, or other bodily secretions of a person infected with Lassa fever. This course provides a general introduction to Lassa fever and is intended for personnel responding to outbreaks in complex emergencies or in settings where the basic environmental infrastructures have been damaged or destroyed. (WHO)
<a href="/items/browse?advanced%5B0%5D%5Belement_id%5D=39&advanced%5B0%5D%5Btype%5D=is+exactly&advanced%5B0%5D%5Bterms%5D=WHO">WHO</a>
2018-07-05
2023-10-17 by Darrell Ruby, T & E group
2025-10-17
Fièvre de Lassa: Introduction
<a href="/items/browse?advanced%5B0%5D%5Belement_id%5D=49&advanced%5B0%5D%5Btype%5D=is+exactly&advanced%5B0%5D%5Bterms%5D=Contenu+Fran%C3%A7ais">Contenu Français</a>
Online course created by the WHO. This course is also available in <a href="https://repository.netecweb.org/items/show/292">English</a>.
<a href="/items/browse?advanced%5B0%5D%5Belement_id%5D=39&advanced%5B0%5D%5Btype%5D=is+exactly&advanced%5B0%5D%5Bterms%5D=WHO">WHO</a>
2018
2024-03-27 R-Lead – never reviewed – make due in 6 months
2024-11-27
Prioritizing diseases for research and development in emergency contexts
<a href="/items/browse?advanced%5B0%5D%5Belement_id%5D=49&advanced%5B0%5D%5Btype%5D=is+exactly&advanced%5B0%5D%5Bterms%5D=General">General</a>
Worldwide, the number of potential pathogens is very large, while the resources for disease research and development (R&D) is limited. To ensure efforts under WHO’s R&D Blueprint are focused and productive, a list of diseases and pathogens are prioritized for R&D in public health emergency contexts.
<a href="/items/browse?advanced%5B0%5D%5Belement_id%5D=39&advanced%5B0%5D%5Btype%5D=is+exactly&advanced%5B0%5D%5Bterms%5D=World+Health+Organization">World Health Organization</a>
2022